Nuchjira Takheaw

9PUBLICATIONS
23CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cellular immunologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 26, 2026
Comparative In Vitro Apoptotic Activity of Two Chimeric Anti-CD99 Antibodies Recognizing Distinct CD99 Regions in T-ALL Models.

|Jan 10, 2026
Phenotypic Profiling and Activation-Associated Expression of CD99 Ligands on Human Leukocytes.

Myint Myat Thu, Nuchjira Takheaw, Witida Laopajon

|Oct 03, 2025
Intracellular Antibody Levels Predict Secretion Efficiency in HEK293T Cells Expressing a Chimeric Anti-CD99 Antibody from a Single-Expression Plasmid.

Manatchanok Chinakarapong, Kamonporn Kotemul, Sukrueta Hanprathet

|May 09, 2025
Immune Responses Against SARS-CoV-2 in Previously SARS-CoV-2-Infected Individuals after Receiving a Single Dose of CoronaVac or ChAdOx-1 Vaccine.

Witida Laopajon, Athavudh Deesomchok, Warawut Chaiwong

|Nov 27, 2024
Exploring the Biological Activity of a Humanized Anti-CD99 ScFv and Antibody for Targeting T Cell Malignancies.

Nuchjira Takheaw, Thanathat Pamonsupornwichit, Ratthakorn Chaiwut

|Jun 27, 2024
Engineered CD147-Deficient THP-1 Impairs Monocytic Myeloid-Derived Suppressor Cell Differentiation but Maintains Antibody-Dependent Cellular Phagocytosis Function for Jurkat T-ALL Cells with Humanized Anti-CD147 Antibody.

Thanathat Pamonsupornwichit, Kanokporn Sornsuwan, On-Anong Juntit

Pageof 2

Frequent Collaborators

5 joint publications

Witida Laopajon

5 joint publications

Supansa Pata

2 joint publications

Kamonporn Kotemul

2 joint publications

Watchara Kasinrerk